Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,847 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,849 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00441337 | A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies(MDX1106-01) | completed | Phase 1 | 39 | Bristol-Myers SquibbINDUSTRY | 1 | Feb 20, 2015 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00972036 | Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy | completed | Phase 1 | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 11, 2014 | clinicaltrials |
| NCT00704600 | Nelfinavir, a Phase I/Phase II Rectal Cancer Study(Nelfinavir) | completed | Phase 1 / Phase 2 | 15 | Maastricht Radiation OncologyOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT02308631 | Endoscopically Assisted Colostomy With Colopexy for Critically Ill Patients Without General Anesthesia or Laparotomy(EACC) | completed | Phase 1 | 5 | University of Sao PauloOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01238939 | Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer | completed | Phase 1 | 35 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT00879385 | KRAS Wild-type Metastatic Colorectal Cancer Trial | completed | Phase 1 | 21 | University of UtahOTHER | 1 | Oct 31, 2014 | clinicaltrials |
| NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | completed | Phase 1 | 6 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 6, 2014 | clinicaltrials |
| NCT00905918 | Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer | completed | Phase 1 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT00066430 | Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia | completed | Phase 1 | 18 | AIDS Malignancy ConsortiumNETWORK | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00433576 | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Sep 15, 2014 | clinicaltrials |
| NCT00027534 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 14 | Michael Morse, MDOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00256334 | Resveratrol for Patients With Colon Cancer | completed | Phase 1 | 11 | University of California, IrvineOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00934882 | Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI | completed | Phase 1 | 45 | BayerINDUSTRY | 1 | Jun 2, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00183833 | Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00336141 | Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 10 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00841191 | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | completed | Phase 1 / Phase 2 | 84 | Centocor, Inc.INDUSTRY | 5 | May 14, 2014 | clinicaltrials |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 202 | AmgenINDUSTRY | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00134069 | Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Apr 16, 2014 | clinicaltrials |
| NCT00494221 | A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX | completed | Phase 1 / Phase 2 | 172 | AstraZenecaINDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01364844 | Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors | completed | Phase 1 | 42 | Daiichi SankyoINDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00598247 | A Pilot Study of PPX in Women With Metastatic Colorectal Cancer | completed | Phase 1 | 15 | University of Southern CaliforniaOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT01306630 | A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 24 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00096330 | Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer | completed | Phase 1 | 20 | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00215956 | A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma | completed | Phase 1 | 31 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 23, 2013 | clinicaltrials |
| NCT00002801 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01523353 | Prehabilitation in Liver Surgery | completed | Phase 1 | 37 | Liverpool University Hospitals NHS Foundation TrustOTHER_GOV | 1 | Dec 17, 2013 | clinicaltrials |
| NCT00460603 | Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 187 | PfizerINDUSTRY | 1 | Dec 6, 2013 | clinicaltrials |
| NCT01124630 | Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments | completed | Phase 1 | 21 | Daiichi SankyoINDUSTRY | 1 | Dec 3, 2013 | clinicaltrials |
| NCT00986518 | T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study(STARTREK) | completed | Phase 1 / Phase 2 | 5 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01184482 | Lapatinib and Cetuximab in Patients With Solid Tumors(TYKERB-ITUX 1) | completed | Phase 1 | 22 | Georgetown UniversityOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00132522 | EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide | completed | Phase 1 | 45 | EMD SeronoINDUSTRY | 2 | Oct 25, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00060411 | A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00138177 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00026299 | Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | completed | Phase 1 / Phase 2 | 14 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00004042 | Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Jul 18, 2013 | clinicaltrials |
| NCT00006387 | Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer | completed | Phase 1 | 7 | Fox Chase Cancer CenterOTHER | 0 | Jul 11, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003543 | Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00003427 | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | completed | Phase 1 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00012155 | Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00030342 | Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer | completed | Phase 1 / Phase 2 | 60 | St. Luke's Medical CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00049101 | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00002828 | Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Feb 20, 2015source: clinicaltrials